IDENTIFICATION OF A TRANSCRIPTION-REGULATING FACTOR FOR NUCLEAR ONCOGENES AND ITS APPLICATION FOR DIAGNOSIS
核癌基因转录调控因子的鉴定及其诊断应用
基本信息
- 批准号:04670753
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1992
- 资助国家:日本
- 起止时间:1992 至 1993
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this research porject, we studied the mechanism of expression of an oncogene family, mycs, especially N-myc. The regulatory mechanism of the myc gene transcription is unclear. The myc gene products (c-Myc, N-Myc, and L-Myc) forming hetrodimers with Max are known as transcription factors, though the target gene of the myc gene family are not known, yet. Gene amplification of the myc gene family is also known in certain malignant tumors. There is a correlation between the extent of the N-myc gene amplification and the malignancy in neuroblastoma, indicating that the measurement of the gene amplification potentially has a significance as a tumor maker.In this study, to reveal the regulatory mechanism of N-myc oncogene expression, the transcription regulatory region located at 5'-flanking region of N-myc gene was first investigated. By 1992, N-myc gene including 5'-flanking region in TNB9 neuroblastoma cells of which N-myc gene is amplified was cloned and sequenced. In 1992 and 1993, to identify the control region, a reporter gene assay was carried out using the plasmids derived from N-myc gene of TNB9. Plasmids having CAT gene as a reporter gene and various length of 5'-flanking region, was newly constructed and studied the CAT activity in GOTO neuroblastoma cells as N-myc expressing cells and in HeLaS3 cells as N-myc non-expressing cells. The transcription-promoting and repressing regions were found in N-myc expressing cells and transcription-promoting regions were found in N-myc non-expressing cells. It is likely that there are more than one transcription factors regulating N-myc gene transcription in N-myc expressing cells. The cloning of the factor(s) and further investigation of abnormality of the factor(s) in various malignant tumor are neccessary.
本研究课题研究了癌基因家族myc,尤其是N-myc的表达机制。myc基因转录的调控机制尚不清楚。与Max形成异二聚体的myc基因产物(c-Myc、N-Myc和L-Myc)被称为转录因子,尽管myc基因家族的靶基因尚不清楚。myc基因家族的基因扩增在某些恶性肿瘤中也是已知的。N-myc基因扩增的程度与神经母细胞瘤的恶性程度有关,表明检测N-myc基因扩增可能具有作为肿瘤标志物的意义,为了揭示N-myc癌基因表达的调控机制,本研究首先研究了位于N-myc基因5 '端的转录调控区。到1992年,在扩增出N-myc基因的TNB 9神经母细胞瘤细胞中,克隆了N-myc基因及其5 '侧翼区,并进行了序列测定。在1992年和1993年,为了鉴定对照区,使用来自TNB 9的N-myc基因的质粒进行报告基因测定。以CAT基因为报告基因,5 ′-侧翼区为不同长度的质粒,在N-myc表达细胞后藤神经母细胞瘤细胞和非N-myc表达细胞HeLaS 3中研究了CAT活性。在N-myc表达细胞中发现了转录促进区和转录抑制区,而在N-myc非表达细胞中发现了转录促进区。在表达N-myc的细胞中,可能存在不止一种转录因子调节N-myc基因的转录。因此,克隆该因子并进一步研究其在各种恶性肿瘤中的异常是必要的。
项目成果
期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lie, B., Tunemoto, D., Hemmi, H., Mizukami, Y., Fukuda, H., Kikuchi, H., Kato, S., and Numao N.: "Identification of the binding site of 55kDa tumor necrosis factor receptor by synthetic peptides." Biochem Biophys Res Commun. 188. 503-509 (1992)
Lie, B.、Tunemoto, D.、Hemmi, H.、Mizukami, Y.、Fukuda, H.、Kikuchi, H.、Kato, S. 和 Numao N.:“55kDa 肿瘤坏死结合位点的鉴定
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hemmi,H.: "Pleiotypic Changes in expression of the N-myc gene in neuroblastoma cell lines" Recent Adv.chem.mol Biol.cancer Res.(in press).
Hemmi,H.:“神经母细胞瘤细胞系中 N-myc 基因表达的多型变化”最近的 Adv.chem.mol Biol.cancer Res.(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hemmi, H.: "Heterogeneous erpression of N‐myc oncoprotein: relationship to cell cycle" Clin. Chem. Eng. Commun.(1993)
Hemmi,H.:“N-myc 癌蛋白的异质抑制:与细胞周期的关系”Chem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Inoue, A., Ihara.H., Kon, T., Nakamura.M., Suzuki, J., Aoki, T., Hemmi, H., and Shimatake, H.: "Polymorphism in the human dopamine D4 receptor (DRD4) gene in Japanese detected by PCR.Human Mol Genet" 2. 2197 (1993)
Inoue, A.、Ihara.H.、Kon, T.、Nakamura.M.、Suzuki, J.、Aoki, T.、Hemmi, H. 和 Shimatake, H.:“人类多巴胺 D4 受体的多态性(
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shimatake, H., Shindo, H., Naruki, Y., Ohtsuka, S., Nakagawa, C., Hemmi, H.: "Heterogeneous expression of N-myc oncoprotein : Relationship to cell cycle." Clin Chem Enz Commun. (in press).
Shimatake, H.、Shindo, H.、Naruki, Y.、Ohtsuka, S.、Nakakawa, C.、Hemmi, H.:“N-myc 癌蛋白的异质表达:与细胞周期的关系。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HEMMI Hiromichi其他文献
HEMMI Hiromichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HEMMI Hiromichi', 18)}}的其他基金
Molecular mechanism of hypoxia-induced genome instability in human colorectal cancer
缺氧引起人类结直肠癌基因组不稳定的分子机制
- 批准号:
21591736 - 财政年份:2009
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of easy procedure for determining MSI tumor and its application on diagnosis in colorectal cancer
确定MSI肿瘤的简易程序的开发及其在结直肠癌诊断中的应用
- 批准号:
16591358 - 财政年份:2004
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study for inactivation mechanism of tumor-associated genes in sporadic colorectal cancers
散发性结直肠癌肿瘤相关基因失活机制研究
- 批准号:
13671348 - 财政年份:2001
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of no gene expression of hMLH1 in sporadic colorectal cancers : Identification of transcription factors and its establishment of detection method.
散发性结直肠癌hMLH1基因不表达的机制:转录因子的鉴定及其检测方法的建立。
- 批准号:
10671223 - 财政年份:1998
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of gastrointestinal cancers by abnormal mismatch repair system : Analysis mainly focused in target genes.
异常错配修复系统产生胃肠癌:分析主要集中在目标基因。
- 批准号:
08671488 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Molecular targeted therapy in childhood neuroblastoma based on inhibition of the N-myc oncogene
基于抑制 N-myc 癌基因的儿童神经母细胞瘤分子靶向治疗
- 批准号:
nhmrc : 350885 - 财政年份:2005
- 资助金额:
$ 1.34万 - 项目类别:
NHMRC Project Grants
Downregulation of N-myc oncogene expression as a therapeutic strategy for childhood neuroblastoma.
N-myc 癌基因表达下调作为儿童神经母细胞瘤的治疗策略。
- 批准号:
nhmrc : 209600 - 财政年份:2002
- 资助金额:
$ 1.34万 - 项目类别:
NHMRC Project Grants
The role of the N-myc oncogene in mediating drug resistance and patient outcome in childhood neuroblastoma
N-myc 癌基因在介导儿童神经母细胞瘤耐药性和患者预后中的作用
- 批准号:
nhmrc : 990390 - 财政年份:1999
- 资助金额:
$ 1.34万 - 项目类别:
NHMRC Project Grants
MECHANISM N-MYC ONCOGENE DOWN REGULATION BY VITAMIN D
维生素 D 下调 N-MYC 癌基因的机制
- 批准号:
2112801 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Regulation of the N-myc oncogene in neuroblastoma
神经母细胞瘤中 N-myc 癌基因的调控
- 批准号:
6689534 - 财政年份:1995
- 资助金额:
$ 1.34万 - 项目类别:
REGULATION OF THE N MYC ONCOGENE IN NEUROBLASTOMA
N MYC 癌基因在神经母细胞瘤中的调控
- 批准号:
2591755 - 财政年份:1995
- 资助金额:
$ 1.34万 - 项目类别:
Regulation of the N-myc oncogene in neuroblastoma
神经母细胞瘤中 N-myc 癌基因的调控
- 批准号:
6621266 - 财政年份:1995
- 资助金额:
$ 1.34万 - 项目类别:
REGULATION OF THE N-MYC ONCOGENE IN NEUROBLASTOMA
N-MYC 癌基因在神经母细胞瘤中的调控
- 批准号:
2273665 - 财政年份:1995
- 资助金额:
$ 1.34万 - 项目类别:
REGULATION OF THE N-MYC ONCOGENE IN NEUROBLASTOMA
N-MYC 癌基因在神经母细胞瘤中的调控
- 批准号:
2273667 - 财政年份:1995
- 资助金额:
$ 1.34万 - 项目类别:
REGULATION OF THE N-MYC ONCOGENE IN NEUROBLASTOMA
N-MYC 癌基因在神经母细胞瘤中的调控
- 批准号:
2423359 - 财政年份:1995
- 资助金额:
$ 1.34万 - 项目类别:














{{item.name}}会员




